Publications by authors named "Mark L Graham"

Claim this Profile
R
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.
Dawn L Hershman, Joseph M Unger, Grace Clarke Hillyer, Anna Moseley, Kathryn B Arnold, Mark L Graham

J Clin Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603).
Roberto A Leon-Ferre, Paul J Novotny, Eric G Wolfe, Stephanie S Faubion, Kathryn J Ruddy, Mark L Graham

JNCI Cancer Spectr· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Eleftherios P Mamounas, Hanna Bandos, Barry C Lembersky, Jong-Hyeon Jeong, Charles E Geyer, Mark L Graham

Lancet Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group.
Ruta D Rao, Melody A Cobleigh, Robert Gray, Mark L Graham, Larry Norton

Med Oncol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study.
William J Irvin, Christine M Walko, Karen E Weck, Joseph G Ibrahim, Wing K Chiu, Mark L Graham

J Clin Oncol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer.
Lisa R Susswein, Cécile Skrzynia, Leslie A Lange, Jessica K Booker, Mark L Graham

J Clin Oncol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Lisa A Carey, E Claire Dees, Lynda Sawyer, Lisa Gatti, Dominic T Moore, Mark L Graham

Clin Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response and cardiac toxicity of trastuzumab given in conjunction with weekly paclitaxel after doxorubicin/cyclophosphamide.
Hanna Kelly, Gretchen Kimmick, E Claire Dees, Frances Collichio, Lisa Gatti, Mark L Graham

Clin Breast Cancer· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome.
Lisa A Carey, Richard Metzger, E Claire Dees, Frances Collichio, Carolyn I Sartor, Mark L Graham

J Natl Cancer Inst· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system metastases in women after multimodality therapy for high risk breast cancer.
Lisa A Carey, Matthew G Ewend, Richard Metzger, Lynda Sawyer, E Claire Dees, Mark L Graham

Breast Cancer Res Treat· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
Eric P Winer, Donald A Berry, Susan Woolf, David Duggan, Alice Kornblith, Mark L Graham

J Clin Oncol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis